Weight loss decreases risk of breast cancer in susceptible womenAugust 22, 2005Women with a mutation in the gene BRCA1, which predisposes women to breast cancer, are 65% less likely to develop the disease if they lose weight between 18 and 30 years of age. Research published in the open access journal Breast Cancer Research suggests that young women with this genetic predisposition should avoid putting on weight in early adulthood, especially if they plan to have children. Steven Narod from the University of Toronto, Canada, and colleagues from universities in Canada, the USA and Poland studied two groups of women, all of whom had a mutation in one of the breast cancer susceptibility genes BRCA1 and BRCA2. The first group had been diagnosed with breast cancer while the second group had not. Each member of the first group was paired up, or 'matched', with a woman from the second group who was the same age, carried a mutation in the same gene and lived in the same country. This is the largest study of this kind to date, with 1073 women from five different countries in each group. By comparing the two groups, the researchers could identify the relationship between the incidence of breast cancer before the menopause in women at risk, and weight at 18, 30 and 40 years of age. Their results show that, for women who have a mutation in BRCA1, "weight loss of at least 10 pounds was associated with a 65% reduction in cancer risk between ages 30 and 40." The study also shows that BRCA1 mutation carriers who gained 10 pounds or more between 18 and 30 years of age are 44% more at risk of developing breast cancer if they have 2 children or more. No association between weight loss and breast cancer risk was shown in BRCA2 mutation carriers. BioMed Central |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||